Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Opus Genetics

    Client Virtual Booth

    OPUS GENETICS

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Opus Genetics
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Raleigh, NC
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://opusgtx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/opus-genetics/?viewAsMember=true
    Twitter
    Twitter
    https://twitter.com/OpusGenetics

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Opus Announces Comp of Dosing of Ph 1/2 of OPGx-LCA5 for Retinal Disease LCA5
    Opus Announces Comp of Dosing of Ph 1/2 of OPGx-LCA5 for Retinal Disease LCA5

    https://www.globenewswire.com/news-release/2024/03/26/2852307/0/en/Opus-Genetics-Announces-Completion-of-Dosing-in-First-Cohort-of-Phase-1-2-Trial-of-Gene-Therapy-OPGx-LCA5-in-Patients-with-Rare-Inherited-Retinal-Disease-LCA5.html

    GLOBENEWSWIRE
    26 Mar 2024
    Share Share
    Data on Potential of Opus AAV-based Gene Therapy to be Presented
    Data on Potential of Opus AAV-based Gene Therapy to be Presented

    https://www.globenewswire.com//news-release/2023/11/03/2773418/0/en/New-Preliminary-Clinical-Data-on-Potential-of-Opus-AAV-based-Gene-Therapy-for-Rare-Inherited-Retinal-Disease-to-be-Presented-at-the-American-Academy-of-Ophthalmology-Annual-Confere.html

    GLOBENEWSWIRE
    03 Nov 2023
    Share Share
    Opus Genetics Announces First Patient Dosed in Phase 1/2 Trial of OPGx-LCA5
    Opus Genetics Announces First Patient Dosed in Phase 1/2 Trial of OPGx-LCA5

    https://www.globenewswire.com//news-release/2023/09/07/2739303/0/en/Opus-Genetics-Announces-First-Patient-Dosed-in-Phase-1-2-Trial-of-Gene-Therapy-OPGx-LCA5-in-Patients-with-Rare-Inherited-Retinal-Disease-LCA5.html

    GLOBENEWSWIRE
    07 Sep 2023
    Share Share
    Opus Genetics acquires two gene therapy candidates from Iveric Bio
    Opus Genetics acquires two gene therapy candidates from Iveric Bio

    https://www.healio.com/news/ophthalmology/20221229/opus-genetics-acquires-two-gene-therapy-candidates-from-iveric-bio#:~:text=Opus%20Genetics%20has%20acquired%20the,to%20a%20company%20press%20release.

    HEALIO
    29 Dec 2022
    Share Share
    Opus Genetics Receives FDA Clearance of IND Application for OPGx-001
    Opus Genetics Receives FDA Clearance of IND Application for OPGx-001

    https://www.globenewswire.com//news-release/2022/12/01/2565888/0/en/Opus-Genetics-Receives-FDA-Clearance-of-IND-Application-for-OPGx-001-a-Gene-Therapy-Candidate-Intended-for-the-Treatment-of-Rare-Inherited-Retinal-Disease-LCA5.html

    GLOBENEWSWIRE
    01 Dec 2022
    Share Share
    Opus Genetics Sponsors Uni-Rare Natural History Study for People with IRD
    Opus Genetics Sponsors Uni-Rare Natural History Study for People with IRD

    https://www.globenewswire.com/news-release/2022/11/14/2554980/0/en/Opus-Genetics-Sponsors-Uni-Rare-Natural-History-Study-for-People-with-Inherited-Retinal-Diseases.html

    BIOSPACE
    14 Nov 2022
    Share Share
    Opus Genetics Expands Board Directors with Appointment of Global Ophthalmology
    Opus Genetics Expands Board Directors with Appointment of Global Ophthalmology

    https://www.globenewswire.com/news-release/2022/09/27/2523209/0/en/Opus-Genetics-Expands-Board-of-Directors-with-Appointment-of-Global-Ophthalmology-Leader-Dr-Adrienne-Graves.html

    GLOBENEWSWIRE
    27 Sep 2022
    Share Share
    Opus Genetics Leadership to Present at 3rd Annual Gene Therapy for Ophthalmic
    Opus Genetics Leadership to Present at 3rd Annual Gene Therapy for Ophthalmic

    https://www.globenewswire.com/news-release/2022/09/12/2514079/0/en/Opus-Genetics-Leadership-to-Present-at-3rd-Annual-Gene-Therapy-for-Ophthalmic-Disorders-Conference.html

    GLOBENEWSWIRE
    12 Sep 2022
    Share Share
    Opus Genetics Hosts Inaugural Patient Advocacy Outreach Webinar
    Opus Genetics Hosts Inaugural Patient Advocacy Outreach Webinar

    https://www.globenewswire.com/news-release/2022/09/01/2508559/0/en/Opus-Genetics-Hosts-Inaugural-Patient-Advocacy-Outreach-Webinar-on-Inherited-Retinal-Diseases.html

    GLOBENEWSWIRE
    01 Sep 2022
    Share Share
    Opus Genetics to Present at OIS Retina Innovation Summit 2022
    Opus Genetics to Present at OIS Retina Innovation Summit 2022

    https://www.globenewswire.com/news-release/2022/07/11/2477178/0/en/Opus-Genetics-to-Present-at-OIS-Retina-Innovation-Summit-2022.html

    GLOBENEWSWIRE
    11 Jul 2022
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    veranova-m-2024-04-22

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search